Rallybio Corp (RLYB)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Martin W. MacKay |
Employees: | 40 |
Web site: | rallybio.com |
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
203- 859-3820
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
Rallybio Corporation engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT)
Please log in first to see chart